Key result
An annual preventative supplementary immunization strategy resulted in an 80% probability of no polio outbreaks when routine immunization coverage was ≥50%, whereas a strategy without preventative campaigns required ≥75% coverage to achieve equivalent risk.
Why the study?
Preventing wild poliovirus importations and spread is critical, but preventative supplementary immunisation activities have been scaled down recently due to financial constraints.
Does the addition of annual or biannual preventative supplementary immunisation activities (pSIAs) to routine immunisation and outbreak response reduce the risk of wild poliovirus outbreaks and paralytic cases in polio-free settings?
Does the addition of annual or biannual preventative supplementary immunisation activities (pSIAs) to routine immunisation and outbreak response reduce the risk of wild poliovirus outbreaks and paralytic cases in polio-free settings?
In polio-free settings with low routine immunization coverage, preventative supplementary immunization activities are critical to maintaining a high probability of preventing wild poliovirus outbreaks.
Answers are grounded in this paper and cite their sources.
Reemergence of wild polio in Africa underscores immunity gaps; leaves open optimal SIA strategies under financial constraints.
Background Polio eradication was threatened in 2022 by importation of wild poliovirus serotype 1 into Malawi with subsequent international spread, representing the first wild polio cases in Africa since 2014. Preventing importations and spread of wild poliovirus is critical, and dependent on population immunity provided through routine immunisation and supplementary immunisation activities (SIAs). However, the scale of preventative SIAs has reduced in recent years due to financial constraints. Methods We developed a mathematical model of polio transmission dynamics to evaluate the probability of an outbreak, expected number of poliomyelitis cases, and the costs associated with vaccination delivery through routine immunisation (RI), outbreak response SIAs (oSIAs) and preventative SIAs (pSIAs). Across varying levels of routine immunisation coverage, we explore three key strategies: RI+oSIAs, RI+oSIAs+annual pSIAs, and RI+oSIAs+biannual pSIAs. Results The annual pSIA strategy (RI+oSIAs+annual pSIAs) had higher costs but greater probability of no outbreaks: under our model assumptions, annual pSIAs result in 80% probability of no outbreaks when routine immunisation coverage ≥50%. The biannual pSIA strategy (RI+oSIAs+biannual pSIAs) costs less and averts more outbreaks than RI+oSIAs, but RI coverage ≥65% was required to achieve equivalent risk of no outbreaks. The strategy with no pSIAs (RI+oSIAs) had the lowest costs but required ≥75% RI coverage to achieve equivalent risk of no outbreaks. Conclusion Prioritisation of pSIAs must balance outbreak risk against implementation costs, ideally favouring the smallest manageable outbreak risk compatible with elimination. We infer that there are few short-term risks due to population immunity from RI, but without pSIAs, long-term risks accumulate and can result in outbreaks with potential for international spread. We do not consider the costs of further delaying the eradication timeline or societal implications of outbreaks, both of which emphasise the need for pSIAs.
No takes yet. Share an insight, caveat, or question.
Auzenbergs et al. (2023) studied Wild poliomyelitis (n=8,000,000). Annual preventative supplementary immunization activities (pSIAs) vs. Routine immunization (RI) and outbreak response SIAs (oSIAs) only was evaluated on Probability of no outbreaks. An annual preventative supplementary immunization strategy resulted in an 80% probability of no polio outbreaks when routine immunization coverage was ≥50%, whereas a strategy without preventative campaigns required ≥75% coverage to achieve equivalent risk.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: